Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02903160
Title Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Cabazitaxel + Carboplatin + Enzalutamide + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.